Dana Edwards

Dana Edwards currently serves as the Senior Vice President and Global Head of Sales and Marketing for Life Sciences and Healthcare at Clarivate, a position held since May 2025. Prior to this role, Dana held the title of Chief Commercial Officer at both Endpoint Clinical and Neovance, which were Arsenal Portfolio Companies divested from Fortrea in June 2024. Dana also served as the VP and Global Head of Commercial for Enabling Services at Fortrea before its divestment, and has experience as Chief Operating Officer and Chief Commercial Officer at Circuit Clinical from October 2021 to August 2023. Dana holds a Bachelor of Science degree in Chemistry/Biochemistry from the University of North Carolina at Chapel Hill, obtained between January 1995 and January 1999.